How Safe are Fluoroquinolones for Diabetic Patients? A Systematic Review of Dysglycemic and Neuropathic Effects of Fluoroquinolones

INTRODUCTION: The US Food and Drug Administration issued safety warnings about neuropathy in 2013 and dysglycemia in 2018 caused by fluoroquinolone use, mainly based on case reports and case series. We conducted this systematic review to evaluate the safety of fluoroquinolones in diabetic patients b...

Descripción completa

Detalles Bibliográficos
Autores principales: Althaqafi, Abdulrhman, Ali, Majid, Alzahrani, Yusuf, Ming, Long Chiau, Hussain, Zahid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520959/
https://www.ncbi.nlm.nih.gov/pubmed/34675522
http://dx.doi.org/10.2147/TCRM.S284171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520959/
https://www.ncbi.nlm.nih.gov/pubmed/34675522
http://dx.doi.org/10.2147/TCRM.S284171

Ejemplares similares